Balaji Amines Limited

BSE:530999 Lagerbericht

Marktkapitalisierung: ₹62.2b

Balaji Amines Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Balaji Amines wird voraussichtlich seinen Umsatz steigern um 12% pro Jahr.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Chemicals Gewinnwachstum19.4%
Wachstumsrate der Einnahmen12.0%
Zukünftige Eigenkapitalrendite9.60%
Analystenabdeckung

Low

Zuletzt aktualisiert26 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update May 21

530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism

Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Narrativ-Update May 07

530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside

Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.
Narrativ-Update Apr 23

530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside

Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.
Narrativ-Update Apr 08

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Narrativ-Update Mar 24

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.
Narrativ-Update Mar 10

530999: Refined Margins And P E Assumptions Will Likely Support Returns

Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).
Narrativ-Update Feb 23

530999: Higher Future P E And Margins Will Likely Support Returns

Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.
Narrativ-Update Feb 09

530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing

Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Narrativ-Update Jan 25

530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins

Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).
Narrativ-Update Jan 10

530999: Stable Margins And Upcoming Results Will Support Further Upside

Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).
Narrativ-Update Dec 25

530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins

Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.
Narrativ-Update Dec 11

530999: Stable Margins And Growth Outlook Will Support Further Upside

Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
Narrativ-Update Nov 27

530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales

Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.
Narrativ-Update Sep 05

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
User avatar
Neues Narrativ Feb 02

New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential

New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.

Gewinn- und Umsatzwachstumsprognosen

BSE:530999 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/202920,625N/AN/AN/A1
3/31/202818,043N/AN/AN/A1
3/31/202716,306N/AN/AN/A1
3/31/202614,2501,672-3,5591,840N/A
12/31/202513,8291,441N/AN/AN/A
9/30/202513,6431,458-2,126824N/A
6/30/202513,7071,522N/AN/AN/A
3/31/202513,9711,5754852,554N/A
12/31/202414,5831,855N/AN/AN/A
9/30/202415,2892,0179393,605N/A
6/30/202415,6261,954N/AN/AN/A
3/31/202416,4152,0496853,341N/A
12/31/202316,9901,842N/AN/AN/A
9/30/202319,0191,9741,6013,567N/A
6/30/202321,4892,553N/AN/AN/A
3/31/202323,5543,2552,1483,540N/A
12/31/202226,6523,868N/AN/AN/A
9/30/202226,4514,1382,1023,280N/A
6/30/202225,4334,010N/AN/AN/A
3/31/202223,2293,6847142,196N/A
12/31/202119,5983,442N/AN/AN/A
9/30/202117,8443,296-546715N/A
6/30/202115,4112,956N/AN/AN/A
3/31/202113,1332,382-2211,099N/A
12/31/202011,5921,845N/AN/AN/A
9/30/20209,9461,329121975N/A
6/30/20209,3951,186N/AN/AN/A
3/31/20209,3951,0488241,442N/A
12/31/20199,0951,000N/AN/AN/A
9/30/20199,2141,029N/A1,042N/A
6/30/20199,3191,036N/AN/AN/A
3/31/20199,4681,175N/A942N/A
3/31/20188,6441,132N/A1,400N/A
3/31/20176,730824N/A605N/A
3/31/20166,446576N/A848N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von 530999 über der Sparquote liegt (6.9%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von 530999 schneller wachsen werden als der Markt Indian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 530999 in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: 530999Die Einnahmen des Unternehmens (12% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.7% pro Jahr).

Hohe Wachstumseinnahmen: 530999Die Einnahmen des Unternehmens (12% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 530999Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.6%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/26 15:33
Aktienkurs zum Tagesende2026/05/26 00:00
Gewinne2026/03/31
Jährliche Einnahmen2026/03/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Balaji Amines Limited wird von 4 Analysten beobachtet. 1 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Nilesh GhugeHDFC Securities Limited
Jay GandhiHDFC Securities Limited
Keshav LahotiHDFC Securities Limited